FHA
RYTM icon

First Horizon Advisors’s Rhythm Pharmaceuticals RYTM Stock Holding History

First Horizon Advisors’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$12.6K Buy
+200
New +$12.2K ﹤0.01% 1593

Other funds holding RYTM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

First Horizon Advisors's RYTM Position: Q2 2025 in Review

First Horizon Advisors opened a new position in Rhythm Pharmaceuticals (RYTM) in Q2 2025: 200 shares worth $12.6K. The stake represents ﹤0.01% of the portfolio and ranks #1593 among its holdings.

227 funds tracked by Wall St. Rank hold RYTM as of Q2 2025.

  • First Horizon Advisors held 200 shares of Rhythm Pharmaceuticals worth $12.6K as of Q2 2025.
  • Rhythm Pharmaceuticals was a new First Horizon Advisors position in Q2 2025.
  • Rhythm Pharmaceuticals made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1593 holding.
  • 227 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.